Brielle Benyon | Authors

February 11, 2021

High response rates with novel eganelisib plus PD-1 inhibition is reported in patients with metastatic urothelial carcinoma, especially those with low PD-L1 expression.

January 28, 2021

Results from the 2020 World Conference on Lung Cancer Singapore demonstrated the feasibility of using STK11 mutations and immune-related adverse events as response predictors in patients with non–small cell lung cancer.

January 15, 2021

Cancertrialsearch.com helped to match patients with gastrointestinal cancers to clinical trials using 7 different criteria, possibly paving the way for patients to find, understand, and enroll in oncology clinical trials.

December 14, 2020

Patients with aggressive lymphomas had a sharp increase in quality of life from time of diagnosis until 1 year later.

December 13, 2020

A recent study found a difference in preference when it came to the administration of rituximab in patients with blood cancer.

December 09, 2020

Study results suggested that while chemotherapy-induced nausea/vomiting (CINV) can be treated, there is potential for it to return, especially for patients for whom CINV treatment did not work the first time around.

September 22, 2020

The study found that that weekly dose-dense chemotherapy is not superior to standard 3 weekly chemotherapy for patients with epithelial ovarian cancer with regard to progression-free survival and overall survival.

July 23, 2020

Recent study results revealed the most prevalent concerns of oncology nurses during the coronavirus disease 2019 outbreak

July 23, 2020

Despite a recent surge in the need for and use of telemedicine, in home infusions are still not recommended.

July 23, 2020

A proposed bill in the US House of Representatives would get rid of debt for healthcare workers who are treating COVID-19 patients.